Emergency COVID-19 vaccine approval to require 2 months of follow-up data, FDA says
October 07, 2020 at 12:48 PM EDT
The data will help to "provide adequate information to assess a vaccine’s benefit-risk profile including adverse events."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.